Tag: SANOFI-AVENTIS

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to SANOFI-AVENTIS

Eli Lilly, other Big Pharma firms are making it harder for low-income patients to get discount drugs ...

Added to Collection on: 2021-01-04 11:02:55

Tags for this article:

Companies
Life Sciences
Health sciences
CAC 40
Sanofi
Novo Nordisk
Novartis
AstraZeneca
United Therapeutics
SANOFI-AVENTIS

Click the tags to see associated articles and topics

View Article Details
Sanofi – Consensus Indicates Potential 31.6% Upside

Added to Collection on: 2021-01-27 21:22:30

Tags for this article:

Drugs
Clinical medicine
Medicine
Sanofi
Insulin glargine/lixisenatide
Insulin glulisine
Insulin
Alglucosidase alfa
Iduronidase
Lixisenatide
Alemtuzumab
Thymoglobulin
SANOFI-AVENTIS

Click the tags to see associated articles and topics

View Article Details
Sanofi – Consensus Indicates Potential 36.7% Upside

Added to Collection on: 2021-02-19 15:11:15

Tags for this article:

Sanofi
Drugs
Clinical medicine
Medical specialties
Sevelamer
Alirocumab
Insulin
Thymoglobulin
Sarilumab
Lixisenatide
Genzyme
SANOFI-AVENTIS

Click the tags to see associated articles and topics

View Article Details
Sanofi – Consensus Indicates Potential 25.2% Upside

Added to Collection on: 2021-05-08 10:07:30

Tags for this article:

Health care
Health
Sanofi
CAC 40
Vaccination
SNY
Vaccine
GlaxoSmithKline
Lotion
Sanofi Pasteur
DTaP-Hib vaccine
SANOFI-AVENTIS

Click the tags to see associated articles and topics

View Article Details
Patent Owners Are Throwing In the Towel on Arthrex — With a Couple Exceptions

Added to Collection on: 2021-07-08 16:41:15

Tags for this article:

Companies
Patent law
Uniloc
Kramer Levin Naftalis & Frankel
Industry economics)
Sanofi
Qualcomm
Technology
SANOFI-AVENTIS

Click the tags to see associated articles and topics

View Article Details
Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology

Added to Collection on: 2021-07-29 13:18:45

Tags for this article:

Drugs
Health care
Health
Monoclonal antibodies
Breakthrough therapy
Ocrelizumab
Rituximab
CD20
Natalizumab
Multiple sclerosis
Ofatumumab
Draft:Teresa Frohman
Biogen Idec
Genzyme
Teva
Novartis
Ann Neurol
Celgene
Merck
Almirall
SANOFI-AVENTIS
sanofi-genzyme

Click the tags to see associated articles and topics

View Article Details
Linklaters advises eureKING, the first european Special Purpose Acquisition Company ...

Added to Collection on: 2022-05-14 11:27:09

Tags for this article:

Law firms
Corporate finance
Private equity
Special-purpose acquisition company
linklaters
Associate
SANOFI-AVENTIS
Panasonic

Click the tags to see associated articles and topics

View Article Details
HRSA ADR Panel Dismisses NACHC's 340B Complaint Against Two Drug Manufacturers

Added to Collection on: 2022-10-17 20:08:33

Tags for this article:

Pharmaceuticals policy
Health Resources and Services Administration
Pharmaceutical industry in China
Pharmacy in China
Science and technology in the People's Republic of China
Pharmaceutical industry in Bangladesh
340B Drug Pricing Program
Healthcare Systems Bureau
SANOFI-AVENTIS
AstraZeneca Pharm

Click the tags to see associated articles and topics

View Article Details